Michael Alfieri Insider Profile
11 Followers
Michael Alfieri, PFO at Aldeyra Therapeutics, holds 7.50K shares in Aldeyra Therapeutics (Ticker: ALDX), holds 10.00K shares in Genocea Biosciences (Ticker: GNCAQ). Most recently, Michael Alfieri Bought ― shares of Aldeyra Therapeutics on Mar 19, 2026 for an estimated value of $7.10K.
Profitable Transactions
0 out of 3 Profitable Transactions
Average Return
-33.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Michael Alfieri's holdings
Insider Roles
PFO
Roles that Michael Alfieri holds in companies
Most Profitable Insider Trade
Stock:
Genocea Biosciences
(GNCAQ)
(GNCAQ)
Rating:Informative Buy
Date:Sep 14, 2018 - Sep 14, 2019
Return:-14.40%
The most profitable trade made by Michael Alfieri
Michael Alfieri's Trading History
Aldeyra Therapeutics
Mar 19, 2026
PFO
Informative Buy
7.10K
$11.63K
Genocea Biosciences
Sep 14, 2018
―
Informative Buy
5.40K
―
List of latest transactions for each holding click on a transaction to see Michael Alfieri's performance on stock
You May Also Like
Michael Alfieri insider profile FAQ
What is the percentage of profitable transactions made by Michael Alfieri?
The percentage of profitable transactions made by Michael Alfieri is 0%.
What is the average return per transaction made by Michael Alfieri?
The average return per transaction made by Michael Alfieri is -33.30%.
What stocks does Michael Alfieri hold?
Michael Alfieri holds: ALDX, GNCAQ stocks.
What was Michael Alfieri’s latest transaction?
Michael Alfieri latest transaction was an Informative Buy of $7.10K.
What was Michael Alfieri's most profitable transaction?
Michael Alfieri’s most profitable transaction was an Informative Buy of GNCAQ stock on September 14, 2018. The return on the trade was -14.40%.
What is Michael Alfieri's role in Aldeyra Therapeutics?
Michael Alfieri's role in Aldeyra Therapeutics is PFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.